Efficacy/tolerance profile of agomelatine and practical use in depressed patients

被引：0

作者：

Rouillon, F ^{[1
]}

机构：

[1] Hop Andre Chenevier, Dept Psychiat, Creteil, France

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2005年 / 15卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S660 / S661

页数：2

共 50 条

[1] Efficacy and tolerance profile of agomelatine and practical use in depressed patients
Rouillon, F
[J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 : S31 - S35
[2] Favorable sexual profile of agomelatine in depressed patients
Kennedy, S. H.
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S319 - S319
[3] The efficacy of agomelatine in previously treated depressed patients
Kasper, S.
Hajak, G.
[J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2010, 14 : 26 - 27
[4] The efficacy of agomelatine in previously-treated depressed patients
Kasper, Siegfried
Hajak, Goeran
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (08) : 814 - 821
[5] EFFICACY AND SAFETY OF AGOMELATINE IN DEPRESSED THAI PATIENTS INCLUDING THE ELDERLY DEPRESSED POPULATION
Suraaroonsamrit, B.
[J]. VALUE IN HEALTH, 2013, 16 (07) : A542 - A542
[6] AGOMELATINE, THE FIRST MELATONERGIC ANTIDEPRESSANT: A SUSTAINED EFFICACY IN SEVERELY DEPRESSED PATIENTS
Montgomery, S. A.
Hale, A.
Goodwin, G. M.
[J]. EUROPEAN PSYCHIATRY, 2010, 25
[7] Agomelatine: Innovation for the Benefit of Depressed Patients
Frédéric Rouillon
[J]. CNS Drugs, 2009, 23 : 1 - 2
[8] CLINICAL EXPERIENCE WITH AGOMELATINE IN DEPRESSED PATIENTS
Hajak, G.
[J]. EUROPEAN PSYCHIATRY, 2010, 25
[9] Clinical experience with agomelatine in depressed patients
Goodwin, G.
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S647 - S647
[10] The mechanism, efficacy, and tolerability profile of agomelatine
MacIsaac, Sarah E.
Carvalho, Andre F.
Cha, Danielle S.
Mansur, Rodrigo B.
McIntyre, Roger S.
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (02) : 259 - 274

← 1 2 3 4 5 →